LINC02269

Across TCGA pan-cancer cohorts, LINC02269 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02269 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02269 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02269 expression acts as an unfavorable survival marker, although some lineages such as SARC and PAAD show a favorable association.

LUAD, ACC, and READ are the cancer types where LINC02269 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.514	0.702	<.001	99	view →
ACC	OS	Tertile	All	0.231	0.846	<.001	99	view →
READ	OS	Tertile	II,III,IV	0.736	0.945	<.001	90	view →
KIRP	OS	Tertile	All	0.286	0.726	<.001	81	view →
KIRC	DFS	Tertile	All	0.500	0.693	<.001	76	view →
THCA	OS	Tertile	All	0.880	0.995	<.001	63	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	42	view →
LGG	DFS	Tertile	All	0.575	0.796	<.001	33	view →
UCEC	OS	Tertile	All	0.801	0.885	.010	30	view →
STAD	OS	Tertile	All	0.494	0.634	.004	25	view →
BLCA	OS	Quartile	III,IV	0.545	0.696	.011	24	view →
COAD	DFS	Tertile	II,III,IV	0.600	0.771	.006	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02269–LUAD (DFS)

Open the LUAD breakdown →